 |
|
|
| |
Factors Associated With Weight Loss or Stable Weight After Continuing or Switching to a Doravirine-Based Regimen
|
| |
| |
HIV Drug Therapy Glasgow 2022; October 23-26, 2022; Glasgow, United Kingdom and virtually
Chloe Orkin1; John R. Koethe2; Princy N. Kumar3; Zhi Jin Xu4;
Rebeca M. Plank4; Wayne Greaves4; Peter Sklar4,*; Rima Lahoulou5
1Queen Mary University of London, London, United Kingdom
2Vanderbilt University Medical Center, Nashville, TN, USA
3Medstar Georgetown University Hospital, Washington DC, USA
4Merck & Co., Inc., Rahway, NJ, USA
5MSD France, Puteaux, France
* An employee of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA at the time of the study
|
| |
|
|
|
|
|
